Personalized Cognitive Counseling Reduces Drinking Expectancy Among Men Who Have Sex with Men and Transgender Women in Lima, Peru: A Pilot Randomized Controlled Trial

R. Colby Passaro(corresponding author)
,
Susan Chávez-Gomez
,
Angelica Castañeda-Huaripata
,
Williams Gonzales-Saavedra
,
Matthew R. Beymer
,
Eddy R. Segura

*Corresponding author for this work

David Geffen School of Medicine at UCLA
,
University of South California Medical Center
,
University of California Los Angeles
,
Asociación Civil Via Libre
,
Universidad Peruana de Ciencias Aplicadas
,
University of California, San Francisco

Research Output:

Contribution to journal

Article

Peer-review

Open access

Publication Information

Output type

Research Output:

Contribution to journal

Article

Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 3205-3214 (10 pages)

Journal (Volume, Issue Number)

AIDS and Behavior (Volume 24, Issue 11)

Publication milestones

Published - 01/11/2020

Publication status

Published - 01/11/2020

ISSN

1090-7165

Publication IDs

Scopus: 85084813196
PubMed: 32418164

Abstract

Personalized cognitive counseling (PCC) is an evidence-based intervention designed to modify HIV-related risk behavior. We assessed the impact of PCC on sexual behavior, drinking expectancy, and incidence of sexually transmitted infections (STIs) in a 6-month randomized controlled trial among 153 HIV-uninfected men who have sex with men (MSM) and transgender women (TW) in Peru. Study retention was ≥ 90%, with three HIV infections (3 Control) and 19 cases of GC/CT (10 Control, 9 PCC) at 6 months. There was a decline in condomless receptive anal intercourse in the Control (0.74, 95% CI 0.60–0.91; p < 0.01) and PCC arms (0.72, 0.55–0.94; p = 0.02) at 6-month follow-up. There was a decrease in drinking expectancy at 6 months among participants endorsing alcohol use in the PCC arm (0.89, 0.83–0.96; p < 0.01), versus no change in the Control arm (0.98, 0.92–1.04; p = 0.54). PCC was efficacious in reducing drinking expectancy and HIV risk among MSM and TW in Peru.

Funding Details

Funding for this work was provided by the US National Institute of Health Grants NIH R25 MH087222 and NIH R34 MH 105272 to JLC. Acknowledgements We would like to thank the study participants and staff who devoted their time and efforts to make this project possible. Funding for this work was provided by the US National Institute of Health Grants NIH R25 MH087222 and NIH R34 MH105272 to JLC.

FundersFunding numbers

NIH

R25 MH087222

NIMH

R34MH105272